Amerinet, JBC Labs Sign Agreement for Specialized Compounded Pharmaceutical Products

Amerinet, a national healthcare group purchasing organization, has announced it has signed an agreement with JCB Laboratories, a provider of sterile pharmaceuticals, for custom-formulated materials.

Advertisement

 

These materials, according to an Amerinet news release, include sterile and preservative-free compounds, discontinued or back-ordered products and unique sizes and concentrations.

 

The agreement went into effect May 1 and goes through April 30, 2014.

 

Read the news release about the JCB Labs agreement with Amerinet.

 

View all new Amerinet agreements.

 

More Articles Featuring Amerinet:

Amerinet Names Canonsburg General Hospital Recipient of Healthcare Achievement Award

Amerinet Announces Toolkit and Educational Resources on Healthcare Associated Infections

Amerinet Receives Award for Contributions to Environmentally Responsible Healthcare

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.